Based in New York, Lynn LaPierre is a member of Spencer Stuart's Healthcare Practice and leads the U.S. Biopharma Practice. Lynn has extensive experience in the pharmaceutical and healthcare field, with work spanning both research and development and commercial leadership.
Extensive experience in pharma and legal settings
- Prior to joining Spencer Stuart, Lynn served as executive director for another global executive search firm. In this role, she worked on research and development, commercial and legal searches for pharmaceutical, biotechnology, medical device and healthcare companies globally.
- Previously, Lynn led the life sciences practice at Axiom, a New York–based global professional services firm. There she advised pharmaceutical general counsels across both the US and Europe, and grew the healthcare business significantly over four years.
- Before that, Lynn was a product liability litigator and then served as senior counsel at Catalent Pharma Solutions, where she drafted and negotiated a range of commercial transactions.
- Lynn also spent time as a cognitive neuroscience researcher at both the Mount Sinai School of Medicine and McLean Hospital studying schizophrenia.
Lynn has a bachelor’s degree in business from Cornell University, a master’s degree in neuropsychology from Columbia University and a juris doctor from Boston College.